CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Blue Shield of California

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
A
Index (ASP = 100)
108.1
Vs. acquisition
+5.3%
Brand index
107.7
Biosimilar index
114.4
Contract variability
Medium
Drugs observed
850
States
4

Contracts above the typical acquisition benchmark (102.7) on the median drug.

Thin book — treat these figures as indicative, not comparable.

How this payer prices

On this filing, the median drug carries 328 distinct contracted rates across practices, with 31% of billing volume on the single most common rate — a dispersed, negotiated book.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.